These three cytokines were selected because they are widely involved in the pathophysiology of several arthritis including rheumatoid arthritis; pathology in which IL‐1, IL‐6 and TNF‐α are therapeutic targets. This evidence concerns the gene IL1A and rheumatoid arthritis.